nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Milnacipran—Hypotension—Etoposide—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Milnacipran—Body temperature increased—Gemcitabine—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Dysuria—Epirubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Neutropenia—Epirubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Dizziness—Thiotepa—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Milnacipran—Urticaria—Fluorouracil—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Milnacipran—Pollakiuria—Epirubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Milnacipran—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Milnacipran—Paraesthesia—Etoposide—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Haematuria—Methotrexate—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Weight decreased—Epirubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Dyspnoea—Etoposide—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Somnolence—Etoposide—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Angina pectoris—Doxorubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Vomiting—Thiotepa—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Rash—Thiotepa—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Milnacipran—Dermatitis—Thiotepa—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Headache—Thiotepa—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Decreased appetite—Etoposide—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Milnacipran—Body temperature increased—Cisplatin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Milnacipran—Fatigue—Etoposide—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Milnacipran—Constipation—Etoposide—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Milnacipran—Urinary tract infection—Epirubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Milnacipran—Dysuria—Doxorubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Milnacipran—Neutropenia—Doxorubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Milnacipran—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Milnacipran—Hepatitis—Methotrexate—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Milnacipran—Pollakiuria—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Milnacipran—Asthenia—Gemcitabine—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Milnacipran—Haematuria—Epirubicin—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Milnacipran—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Milnacipran—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Milnacipran—Pruritus—Gemcitabine—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Milnacipran—Nausea—Thiotepa—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Urethral disorder—Methotrexate—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Weight decreased—Doxorubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Milnacipran—Pruritus—Fluorouracil—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Milnacipran—Urticaria—Etoposide—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Milnacipran—Abdominal pain—Etoposide—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Milnacipran—Body temperature increased—Etoposide—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Milnacipran—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Milnacipran—Hepatitis—Epirubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Milnacipran—Eye disorder—Methotrexate—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Milnacipran—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Milnacipran—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Milnacipran—Asthenia—Cisplatin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Cardiac disorder—Methotrexate—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Milnacipran—Haematuria—Doxorubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Milnacipran—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Milnacipran—Urethral disorder—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Milnacipran—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Milnacipran—Angiopathy—Methotrexate—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Milnacipran—Dizziness—Fluorouracil—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Chills—Methotrexate—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Milnacipran—Diarrhoea—Cisplatin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Vomiting—Gemcitabine—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Mental disorder—Methotrexate—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Rash—Gemcitabine—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Dermatitis—Gemcitabine—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Eye disorder—Epirubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Hypersensitivity—Etoposide—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Malnutrition—Methotrexate—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Headache—Gemcitabine—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Flushing—Epirubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Vomiting—Fluorouracil—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Hepatitis—Doxorubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Rash—Fluorouracil—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Dermatitis—Fluorouracil—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Headache—Fluorouracil—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Dysgeusia—Methotrexate—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Asthenia—Etoposide—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Angiopathy—Epirubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.001	0.001	CcSEcCtD
Milnacipran—Chills—Epirubicin—urinary bladder cancer	0.000997	0.000997	CcSEcCtD
Milnacipran—Pruritus—Etoposide—urinary bladder cancer	0.000996	0.000996	CcSEcCtD
Milnacipran—Nausea—Gemcitabine—urinary bladder cancer	0.000979	0.000979	CcSEcCtD
Milnacipran—Vomiting—Cisplatin—urinary bladder cancer	0.000977	0.000977	CcSEcCtD
Milnacipran—Vision blurred—Methotrexate—urinary bladder cancer	0.000974	0.000974	CcSEcCtD
Milnacipran—Mental disorder—Epirubicin—urinary bladder cancer	0.000973	0.000973	CcSEcCtD
Milnacipran—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000972	0.000972	CcSEcCtD
Milnacipran—Rash—Cisplatin—urinary bladder cancer	0.000969	0.000969	CcSEcCtD
Milnacipran—Dermatitis—Cisplatin—urinary bladder cancer	0.000968	0.000968	CcSEcCtD
Milnacipran—Malnutrition—Epirubicin—urinary bladder cancer	0.000967	0.000967	CcSEcCtD
Milnacipran—Diarrhoea—Etoposide—urinary bladder cancer	0.000963	0.000963	CcSEcCtD
Milnacipran—Nausea—Fluorouracil—urinary bladder cancer	0.000963	0.000963	CcSEcCtD
Milnacipran—Eye disorder—Doxorubicin—urinary bladder cancer	0.00096	0.00096	CcSEcCtD
Milnacipran—Flushing—Doxorubicin—urinary bladder cancer	0.000954	0.000954	CcSEcCtD
Milnacipran—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000954	0.000954	CcSEcCtD
Milnacipran—Flatulence—Epirubicin—urinary bladder cancer	0.000953	0.000953	CcSEcCtD
Milnacipran—Tension—Epirubicin—urinary bladder cancer	0.000949	0.000949	CcSEcCtD
Milnacipran—Dysgeusia—Epirubicin—urinary bladder cancer	0.000947	0.000947	CcSEcCtD
Milnacipran—Angiopathy—Doxorubicin—urinary bladder cancer	0.000932	0.000932	CcSEcCtD
Milnacipran—Dizziness—Etoposide—urinary bladder cancer	0.000931	0.000931	CcSEcCtD
Milnacipran—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000926	0.000926	CcSEcCtD
Milnacipran—Leukopenia—Methotrexate—urinary bladder cancer	0.000925	0.000925	CcSEcCtD
Milnacipran—Chills—Doxorubicin—urinary bladder cancer	0.000922	0.000922	CcSEcCtD
Milnacipran—Nausea—Cisplatin—urinary bladder cancer	0.000913	0.000913	CcSEcCtD
Milnacipran—Vision blurred—Epirubicin—urinary bladder cancer	0.000911	0.000911	CcSEcCtD
Milnacipran—Mental disorder—Doxorubicin—urinary bladder cancer	0.0009	0.0009	CcSEcCtD
Milnacipran—Convulsion—Methotrexate—urinary bladder cancer	0.000895	0.000895	CcSEcCtD
Milnacipran—Vomiting—Etoposide—urinary bladder cancer	0.000895	0.000895	CcSEcCtD
Milnacipran—Malnutrition—Doxorubicin—urinary bladder cancer	0.000895	0.000895	CcSEcCtD
Milnacipran—Agitation—Epirubicin—urinary bladder cancer	0.000888	0.000888	CcSEcCtD
Milnacipran—Rash—Etoposide—urinary bladder cancer	0.000888	0.000888	CcSEcCtD
Milnacipran—Dermatitis—Etoposide—urinary bladder cancer	0.000887	0.000887	CcSEcCtD
Milnacipran—Headache—Etoposide—urinary bladder cancer	0.000882	0.000882	CcSEcCtD
Milnacipran—Flatulence—Doxorubicin—urinary bladder cancer	0.000882	0.000882	CcSEcCtD
Milnacipran—Chest pain—Methotrexate—urinary bladder cancer	0.00088	0.00088	CcSEcCtD
Milnacipran—Tension—Doxorubicin—urinary bladder cancer	0.000878	0.000878	CcSEcCtD
Milnacipran—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000876	0.000876	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000873	0.000873	CcSEcCtD
Milnacipran—Syncope—Epirubicin—urinary bladder cancer	0.000867	0.000867	CcSEcCtD
Milnacipran—Leukopenia—Epirubicin—urinary bladder cancer	0.000865	0.000865	CcSEcCtD
Milnacipran—Palpitations—Epirubicin—urinary bladder cancer	0.000854	0.000854	CcSEcCtD
Milnacipran—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00085	0.00085	CcSEcCtD
Milnacipran—Vision blurred—Doxorubicin—urinary bladder cancer	0.000843	0.000843	CcSEcCtD
Milnacipran—Convulsion—Epirubicin—urinary bladder cancer	0.000838	0.000838	CcSEcCtD
Milnacipran—Infection—Methotrexate—urinary bladder cancer	0.000838	0.000838	CcSEcCtD
Milnacipran—Nausea—Etoposide—urinary bladder cancer	0.000836	0.000836	CcSEcCtD
Milnacipran—Hypertension—Epirubicin—urinary bladder cancer	0.000835	0.000835	CcSEcCtD
Milnacipran—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000827	0.000827	CcSEcCtD
Milnacipran—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000826	0.000826	CcSEcCtD
Milnacipran—Chest pain—Epirubicin—urinary bladder cancer	0.000823	0.000823	CcSEcCtD
Milnacipran—Agitation—Doxorubicin—urinary bladder cancer	0.000822	0.000822	CcSEcCtD
Milnacipran—Anxiety—Epirubicin—urinary bladder cancer	0.00082	0.00082	CcSEcCtD
Milnacipran—Skin disorder—Methotrexate—urinary bladder cancer	0.000819	0.000819	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000817	0.000817	CcSEcCtD
Milnacipran—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000815	0.000815	CcSEcCtD
Milnacipran—Dry mouth—Epirubicin—urinary bladder cancer	0.000805	0.000805	CcSEcCtD
Milnacipran—Anorexia—Methotrexate—urinary bladder cancer	0.000804	0.000804	CcSEcCtD
Milnacipran—Syncope—Doxorubicin—urinary bladder cancer	0.000802	0.000802	CcSEcCtD
Milnacipran—Leukopenia—Doxorubicin—urinary bladder cancer	0.000801	0.000801	CcSEcCtD
Milnacipran—Palpitations—Doxorubicin—urinary bladder cancer	0.000791	0.000791	CcSEcCtD
Milnacipran—Hypotension—Methotrexate—urinary bladder cancer	0.000788	0.000788	CcSEcCtD
Milnacipran—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000786	0.000786	CcSEcCtD
Milnacipran—Infection—Epirubicin—urinary bladder cancer	0.000784	0.000784	CcSEcCtD
Milnacipran—Shock—Epirubicin—urinary bladder cancer	0.000776	0.000776	CcSEcCtD
Milnacipran—Convulsion—Doxorubicin—urinary bladder cancer	0.000775	0.000775	CcSEcCtD
Milnacipran—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000774	0.000774	CcSEcCtD
Milnacipran—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000773	0.000773	CcSEcCtD
Milnacipran—Hypertension—Doxorubicin—urinary bladder cancer	0.000772	0.000772	CcSEcCtD
Milnacipran—Tachycardia—Epirubicin—urinary bladder cancer	0.00077	0.00077	CcSEcCtD
Milnacipran—Skin disorder—Epirubicin—urinary bladder cancer	0.000766	0.000766	CcSEcCtD
Milnacipran—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000763	0.000763	CcSEcCtD
Milnacipran—Insomnia—Methotrexate—urinary bladder cancer	0.000763	0.000763	CcSEcCtD
Milnacipran—Chest pain—Doxorubicin—urinary bladder cancer	0.000762	0.000762	CcSEcCtD
Milnacipran—Anxiety—Doxorubicin—urinary bladder cancer	0.000759	0.000759	CcSEcCtD
Milnacipran—Paraesthesia—Methotrexate—urinary bladder cancer	0.000757	0.000757	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000756	0.000756	CcSEcCtD
Milnacipran—Anorexia—Epirubicin—urinary bladder cancer	0.000752	0.000752	CcSEcCtD
Milnacipran—Dyspnoea—Methotrexate—urinary bladder cancer	0.000752	0.000752	CcSEcCtD
Milnacipran—Somnolence—Methotrexate—urinary bladder cancer	0.00075	0.00075	CcSEcCtD
Milnacipran—Dry mouth—Doxorubicin—urinary bladder cancer	0.000745	0.000745	CcSEcCtD
Milnacipran—Dyspepsia—Methotrexate—urinary bladder cancer	0.000742	0.000742	CcSEcCtD
Milnacipran—Hypotension—Epirubicin—urinary bladder cancer	0.000737	0.000737	CcSEcCtD
Milnacipran—Decreased appetite—Methotrexate—urinary bladder cancer	0.000733	0.000733	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000728	0.000728	CcSEcCtD
Milnacipran—Fatigue—Methotrexate—urinary bladder cancer	0.000727	0.000727	CcSEcCtD
Milnacipran—Infection—Doxorubicin—urinary bladder cancer	0.000725	0.000725	CcSEcCtD
Milnacipran—Shock—Doxorubicin—urinary bladder cancer	0.000718	0.000718	CcSEcCtD
Milnacipran—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000716	0.000716	CcSEcCtD
Milnacipran—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000715	0.000715	CcSEcCtD
Milnacipran—Insomnia—Epirubicin—urinary bladder cancer	0.000714	0.000714	CcSEcCtD
Milnacipran—Tachycardia—Doxorubicin—urinary bladder cancer	0.000713	0.000713	CcSEcCtD
Milnacipran—Skin disorder—Doxorubicin—urinary bladder cancer	0.000709	0.000709	CcSEcCtD
Milnacipran—Paraesthesia—Epirubicin—urinary bladder cancer	0.000709	0.000709	CcSEcCtD
Milnacipran—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000706	0.000706	CcSEcCtD
Milnacipran—Dyspnoea—Epirubicin—urinary bladder cancer	0.000703	0.000703	CcSEcCtD
Milnacipran—Somnolence—Epirubicin—urinary bladder cancer	0.000701	0.000701	CcSEcCtD
Milnacipran—Anorexia—Doxorubicin—urinary bladder cancer	0.000696	0.000696	CcSEcCtD
Milnacipran—Dyspepsia—Epirubicin—urinary bladder cancer	0.000695	0.000695	CcSEcCtD
Milnacipran—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000689	0.000689	CcSEcCtD
Milnacipran—Decreased appetite—Epirubicin—urinary bladder cancer	0.000686	0.000686	CcSEcCtD
Milnacipran—Hypotension—Doxorubicin—urinary bladder cancer	0.000682	0.000682	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000681	0.000681	CcSEcCtD
Milnacipran—Fatigue—Epirubicin—urinary bladder cancer	0.00068	0.00068	CcSEcCtD
Milnacipran—Constipation—Epirubicin—urinary bladder cancer	0.000675	0.000675	CcSEcCtD
Milnacipran—Urticaria—Methotrexate—urinary bladder cancer	0.00067	0.00067	CcSEcCtD
Milnacipran—Abdominal pain—Methotrexate—urinary bladder cancer	0.000667	0.000667	CcSEcCtD
Milnacipran—Body temperature increased—Methotrexate—urinary bladder cancer	0.000667	0.000667	CcSEcCtD
Milnacipran—Insomnia—Doxorubicin—urinary bladder cancer	0.00066	0.00066	CcSEcCtD
Milnacipran—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000656	0.000656	CcSEcCtD
Milnacipran—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000651	0.000651	CcSEcCtD
Milnacipran—Somnolence—Doxorubicin—urinary bladder cancer	0.000649	0.000649	CcSEcCtD
Milnacipran—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000645	0.000645	CcSEcCtD
Milnacipran—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000643	0.000643	CcSEcCtD
Milnacipran—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000635	0.000635	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00063	0.00063	CcSEcCtD
Milnacipran—Fatigue—Doxorubicin—urinary bladder cancer	0.000629	0.000629	CcSEcCtD
Milnacipran—Urticaria—Epirubicin—urinary bladder cancer	0.000627	0.000627	CcSEcCtD
Milnacipran—Constipation—Doxorubicin—urinary bladder cancer	0.000624	0.000624	CcSEcCtD
Milnacipran—Body temperature increased—Epirubicin—urinary bladder cancer	0.000624	0.000624	CcSEcCtD
Milnacipran—Abdominal pain—Epirubicin—urinary bladder cancer	0.000624	0.000624	CcSEcCtD
Milnacipran—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000621	0.000621	CcSEcCtD
Milnacipran—Asthenia—Methotrexate—urinary bladder cancer	0.000605	0.000605	CcSEcCtD
Milnacipran—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000597	0.000597	CcSEcCtD
Milnacipran—Pruritus—Methotrexate—urinary bladder cancer	0.000597	0.000597	CcSEcCtD
Milnacipran—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000581	0.000581	CcSEcCtD
Milnacipran—Urticaria—Doxorubicin—urinary bladder cancer	0.00058	0.00058	CcSEcCtD
Milnacipran—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000577	0.000577	CcSEcCtD
Milnacipran—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000577	0.000577	CcSEcCtD
Milnacipran—Diarrhoea—Methotrexate—urinary bladder cancer	0.000577	0.000577	CcSEcCtD
Milnacipran—Asthenia—Epirubicin—urinary bladder cancer	0.000566	0.000566	CcSEcCtD
Milnacipran—Pruritus—Epirubicin—urinary bladder cancer	0.000558	0.000558	CcSEcCtD
Milnacipran—Dizziness—Methotrexate—urinary bladder cancer	0.000558	0.000558	CcSEcCtD
Milnacipran—Diarrhoea—Epirubicin—urinary bladder cancer	0.00054	0.00054	CcSEcCtD
Milnacipran—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000538	0.000538	CcSEcCtD
Milnacipran—Vomiting—Methotrexate—urinary bladder cancer	0.000536	0.000536	CcSEcCtD
Milnacipran—Rash—Methotrexate—urinary bladder cancer	0.000532	0.000532	CcSEcCtD
Milnacipran—Dermatitis—Methotrexate—urinary bladder cancer	0.000531	0.000531	CcSEcCtD
Milnacipran—Headache—Methotrexate—urinary bladder cancer	0.000528	0.000528	CcSEcCtD
Milnacipran—Asthenia—Doxorubicin—urinary bladder cancer	0.000524	0.000524	CcSEcCtD
Milnacipran—Dizziness—Epirubicin—urinary bladder cancer	0.000522	0.000522	CcSEcCtD
Milnacipran—Pruritus—Doxorubicin—urinary bladder cancer	0.000517	0.000517	CcSEcCtD
Milnacipran—Vomiting—Epirubicin—urinary bladder cancer	0.000502	0.000502	CcSEcCtD
Milnacipran—Nausea—Methotrexate—urinary bladder cancer	0.000501	0.000501	CcSEcCtD
Milnacipran—Diarrhoea—Doxorubicin—urinary bladder cancer	0.0005	0.0005	CcSEcCtD
Milnacipran—Rash—Epirubicin—urinary bladder cancer	0.000498	0.000498	CcSEcCtD
Milnacipran—Dermatitis—Epirubicin—urinary bladder cancer	0.000497	0.000497	CcSEcCtD
Milnacipran—Headache—Epirubicin—urinary bladder cancer	0.000494	0.000494	CcSEcCtD
Milnacipran—Dizziness—Doxorubicin—urinary bladder cancer	0.000483	0.000483	CcSEcCtD
Milnacipran—Nausea—Epirubicin—urinary bladder cancer	0.000469	0.000469	CcSEcCtD
Milnacipran—Vomiting—Doxorubicin—urinary bladder cancer	0.000464	0.000464	CcSEcCtD
Milnacipran—Rash—Doxorubicin—urinary bladder cancer	0.00046	0.00046	CcSEcCtD
Milnacipran—Dermatitis—Doxorubicin—urinary bladder cancer	0.00046	0.00046	CcSEcCtD
Milnacipran—Headache—Doxorubicin—urinary bladder cancer	0.000457	0.000457	CcSEcCtD
Milnacipran—Nausea—Doxorubicin—urinary bladder cancer	0.000434	0.000434	CcSEcCtD
